Barinthus Biotherapeutics plc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BRNS

organization

SIC: 2834

Also known as: BARINTHUS BIOTHERAPEUTICS PLC

SEC Insider

$13.1M

132 transactions

Summary

Barinthus Biotherapeutics plc. (BRNS) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $12.6MSales: $462K18 insiders

Date	Insider	Type	Value
2025-06-10	DAWES KAREN A	A	$0
2025-06-10	Scheeren Joseph	A	$0
2025-06-10	Phillips Anne M.	A	$0
2025-06-10	Morgon Pierre A.	A	$0
2025-06-10	Wright Robin	A	$0
2025-06-10	Hammacher Alex	A	$0
2025-02-03	Hooftman Leon(Chief Medical Officer)	A	$0
2025-02-03	Griffiths Graham(Chief Business Officer)	A	$0
2025-02-03	Enright William(Chief Executive Officer)	A	$0
2025-02-03	Brown Gemma(Chief Financial Officer)	A	$0
2024-06-03	Hooftman Leon(Chief Medical Officer)	A	$0
2024-05-10	Wright Robin	A	$0
2024-05-10	Morgon Pierre A.	A	$0
2024-05-10	Hammacher Alex	A	$0
2024-05-10	Phillips Anne M.	A	$0
2024-05-10	Scheeren Joseph	A	$0
2024-05-10	DAWES KAREN A	A	$0
2024-01-02	Brown Gemma(Chief Financial Officer)	A	$0
2024-01-02	Enright William(Chief Executive Officer)	A	$0
2024-01-02	Griffiths Graham(Chief Business Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Barinthus Biotherapeutics plc. — Contributions, Lobbying & Contracts | Poliscope